Arbutus Biopharma
ABUS
#6233
Rank
ยฃ0.64 B
Marketcap
ยฃ3.35
Share price
-1.33%
Change (1 day)
16.10%
Change (1 year)

Revenue for Arbutus Biopharma (ABUS)

Revenue in 2025 (TTM): ยฃ11.44 Million

According to Arbutus Biopharma 's latest financial reports the company's current revenue (TTM ) is ยฃ11.58 Million. In 2024 the company made a revenue of ยฃ4.91 Million a decrease over the revenue in the year 2023 that were of ยฃ14.23 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Arbutus Biopharma from 2008 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ11.44 M132.67%
2024 ยฃ4.91 M-65.47%
2023 ยฃ14.23 M-55.85%
2022 ยฃ32.25 M296.21%
2021 ยฃ8.14 M60.48%
2020 ยฃ5.07 M10.65%
2019 ยฃ4.58 M-2.12%
2018 ยฃ4.68 M-40.84%
2017 ยฃ7.91 M555.19%
2016 ยฃ1.2 M-92.8%
2015 ยฃ16.78 M74.76%
2014 ยฃ9.6 M2.36%
2013 ยฃ9.38 M8.23%
2012 ยฃ8.66 M-20.22%
2011 ยฃ10.86 M-21.36%
2010 ยฃ13.81 M70.89%
2009 ยฃ8.08 M21.1%
2008 ยฃ6.67 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
ยฃ0.10 B 802.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas